WO2003024484A1 - Medicaments pour traiter le prurit - Google Patents

Medicaments pour traiter le prurit Download PDF

Info

Publication number
WO2003024484A1
WO2003024484A1 PCT/JP2002/009439 JP0209439W WO03024484A1 WO 2003024484 A1 WO2003024484 A1 WO 2003024484A1 JP 0209439 W JP0209439 W JP 0209439W WO 03024484 A1 WO03024484 A1 WO 03024484A1
Authority
WO
WIPO (PCT)
Prior art keywords
dermatitis
antagonists
remedies
pruritus
treating
Prior art date
Application number
PCT/JP2002/009439
Other languages
English (en)
French (fr)
Inventor
Masami Narita
Kazutoyo Sato
Kaoru Kobayashi
Original Assignee
Ono Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co., Ltd. filed Critical Ono Pharmaceutical Co., Ltd.
Priority to JP2003528578A priority Critical patent/JPWO2003024484A1/ja
Priority to EP02779881A priority patent/EP1426059A4/en
Priority to US10/489,408 priority patent/US20040235955A1/en
Publication of WO2003024484A1 publication Critical patent/WO2003024484A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PCT/JP2002/009439 2001-09-14 2002-09-13 Medicaments pour traiter le prurit WO2003024484A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2003528578A JPWO2003024484A1 (ja) 2001-09-14 2002-09-13 掻痒症治療剤
EP02779881A EP1426059A4 (en) 2001-09-14 2002-09-13 DRUGS FOR TREATING PRURIT
US10/489,408 US20040235955A1 (en) 2001-09-14 2002-09-13 Remedies for pruritus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-280438 2001-09-14
JP2001280438 2001-09-14

Publications (1)

Publication Number Publication Date
WO2003024484A1 true WO2003024484A1 (fr) 2003-03-27

Family

ID=19104435

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/009439 WO2003024484A1 (fr) 2001-09-14 2002-09-13 Medicaments pour traiter le prurit

Country Status (4)

Country Link
US (1) US20040235955A1 (ja)
EP (1) EP1426059A4 (ja)
JP (1) JPWO2003024484A1 (ja)
WO (1) WO2003024484A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006062069A1 (ja) * 2004-12-06 2006-06-15 Santen Pharmaceutical Co., Ltd. ｐ３８ＭＡＰキナーゼ阻害剤を有効成分とする掻痒治療剤
JP2008530138A (ja) * 2005-02-14 2008-08-07 ザイモジェネティクス，インコーポレイティド Ｉｌ−３１アンタゴニストに対するアトピー性皮膚炎の治療応答を予測する方法
JP2013508325A (ja) * 2009-10-23 2013-03-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ミクロソームプロスタグランジンｅ２シンターゼ−１のインヒビター

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101158603B1 (ko) * 2004-11-24 2012-07-09 알콘, 인코퍼레이티드 비강용 스프레이를 전달하는 방법
AR054336A1 (es) * 2005-03-30 2007-06-20 Astion Dev As Tratamiento de enfermedades dermatologicas y del prurito
US7632509B2 (en) 2005-07-19 2009-12-15 Biosante Pharmaceuticals, Inc. Methods to express recombinant proteins from lentiviral vectors

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047497A2 (en) * 1998-03-13 1999-09-23 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO2000020371A1 (en) * 1998-10-07 2000-04-13 Merck Frosst Canada & Co. Prostaglandin receptor ligands
WO2001019819A2 (en) * 1999-09-14 2001-03-22 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO2001019814A2 (en) * 1999-09-14 2001-03-22 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
US6277846B1 (en) * 1990-05-31 2001-08-21 Allergan Sales, Inc. Use of platelet activating factor antagonists as anti-pruritic agents
US6242493B1 (en) * 1998-03-13 2001-06-05 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
CN1198649C (zh) * 1998-06-03 2005-04-27 盐野义制药株式会社 用于治疗瘙痒的含pgd2受体拮抗剂的药物组合物
AU2001234107A1 (en) * 2000-02-22 2001-09-03 Ono Pharmaceutical Co. Ltd. Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
JP4929472B2 (ja) * 2000-08-22 2012-05-09 小野薬品工業株式会社 カルボン酸誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
WO2002020462A1 (fr) * 2000-09-01 2002-03-14 Ono Pharmaceutical Co., Ltd. Derives d'acide benzoique et medicaments possedant ces derniers comme principe actif
WO2003016254A1 (fr) * 2001-08-09 2003-02-27 Ono Pharmaceutical Co., Ltd. Composes derives d'acide carboxylique et medicaments comprenant ces composes comme principe actif

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047497A2 (en) * 1998-03-13 1999-09-23 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO2000020371A1 (en) * 1998-10-07 2000-04-13 Merck Frosst Canada & Co. Prostaglandin receptor ligands
WO2001019819A2 (en) * 1999-09-14 2001-03-22 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO2001019814A2 (en) * 1999-09-14 2001-03-22 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of EP1426059A4 *
YAMAGUCHI T. ET AL.: "Involvement of EP3 receptors in the prostaglandin E2-induced potentiation of 5-HT-induced ITCH-associated response in mice", SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 25, no. 1-2, 1999, pages 1440, XP002960246 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006062069A1 (ja) * 2004-12-06 2006-06-15 Santen Pharmaceutical Co., Ltd. ｐ３８ＭＡＰキナーゼ阻害剤を有効成分とする掻痒治療剤
JP2008530138A (ja) * 2005-02-14 2008-08-07 ザイモジェネティクス，インコーポレイティド Ｉｌ−３１アンタゴニストに対するアトピー性皮膚炎の治療応答を予測する方法
JP4927762B2 (ja) * 2005-02-14 2012-05-09 ザイモジェネティクス， インコーポレイテッド Ｉｌ−３１アンタゴニストに対するアトピー性皮膚炎の治療応答を予測する方法
US8435745B2 (en) 2005-02-14 2013-05-07 Zymogenetics, Inc. Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
US8926957B2 (en) 2005-02-14 2015-01-06 Zymogenetics, Inc. Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
JP2013508325A (ja) * 2009-10-23 2013-03-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ミクロソームプロスタグランジンｅ２シンターゼ−１のインヒビター

Also Published As

Publication number Publication date
JPWO2003024484A1 (ja) 2004-12-24
EP1426059A1 (en) 2004-06-09
US20040235955A1 (en) 2004-11-25
EP1426059A4 (en) 2007-01-17

Similar Documents

Publication Publication Date Title
WO2002091999A3 (en) Treatment for wounds
WO2009028495A1 (ja) 真菌性皮膚炎用剤
WO2007056491A3 (en) Film-forming resins as a carrier for topical application of pharmacologically active agents
WO2004089380A3 (en) Pharmaceutical use of fused 1,2,4-triazoles
TW200505451A (en) Benzenesulfonamide derivatives
CN109689045A (zh) 大麻素的局部制剂在治疗大疱性表皮松解症和相关结缔组织病症中的用途
MY133303A (en) Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
WO2009032773A3 (en) Compositions and methods for treating demodex infestations
BR112014017158A2 (pt) aberturas tratadas
DK1161248T3 (da) Farmaceutisk sammensætning indeholdende en nitratkilde og et forsurende middel til behandling af åbne sår og forbrændinger
EA200101166A1 (ru) Ингибиторы металлопротеаз
WO2003024484A1 (fr) Medicaments pour traiter le prurit
WO2005070450A8 (de) Verwendung von niedrig dosiertem erythropoietin zur behandlung von akuter oder chronischer niereninsuffizienz und zur behandlung von wunden
ATE329605T1 (de) Zusammensetzungen aus hagebutten als anti- entzündliches natürliches arzneimittel zur erleichterung/verringerung von symptomen, die mit entzündungen und arthritis zusammenhängen
BRPI0506970B8 (pt) derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior
BRPI0519007A2 (pt) agente preventivo ou terapÊutico para glaucoma
WO2007067875A3 (en) Pyridinyl sulfonamide modulators of chemokine receptors
WO2008043074A3 (en) Electrosurgical device
JP2011526258A (ja) 泡状スキンケアクリーム
NZ589971A (en) Emollient composition comprising glycerol, vaseline and liquid paraffin
WO2007061695A3 (en) Bicyclic spirohydantoin cgrp receptor antagonists
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
KR20210126665A (ko) 방사선 피부염의 치료를 위한 국소 BRaF 억제제 조성물의 용도
JP2011001269A (ja) 紫外線誘発皮膚炎又は一次刺激性皮膚炎の予防又は治療用外用剤
Kamel et al. Carboxytherapy for treatment of localized chronic plaque psoriasis: Clinical and histopathologic evaluation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KR KZ LK LR LS LT LU LV MA MD MG MK MW MX MZ NO NZ OM PH PL PT RO SD SE SG SI SK SL TJ TM TN TR TT UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003528578

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002779881

Country of ref document: EP

Ref document number: 10489408

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2002779881

Country of ref document: EP